• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10
    • Buyers' Guide
    • Events
    • Microsites
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10
  • Buyers' Guide
  • Events
  • Microsites
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    Top Features
    Development Options: Orthopedic Device Design

    I, Surgical Robot

    Printer-Friendly: An Additive Manufacturing Update

    Instrumentation Innovations: A Review of Instrument Manufacturing

    The Total Package: Packaging and Sterilization for Orthopedics
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    Orthopedic Innovators
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    Biogennix Rolls Out Agilon Strip Bone Graft

    Global Bone Tumor Ablation Devices Market to Top $111 Million by 2027

    GreenBone Ortho Closes 10 Million Euros Series B Funding Round

    SynerFuse, Cirtec Medical Partner to Develop Back Pain Management Device

    New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    Incorporate Packaging, Sterilization Early in Product Design to Avoid Costly Mistakes

    SynerFuse, Cirtec Medical Partner to Develop Back Pain Management Device

    New Biosealant Could Stabilize Cartilage, Boost Healing After Injury

    HSS and LimaCorporate Open Provider-Based 3D Design and Printing Facility

    Usability, Sustainability Becoming More Relevant in Medtech Packaging
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    Incorporate Packaging, Sterilization Early in Product Design to Avoid Costly Mistakes

    Usability, Sustainability Becoming More Relevant in Medtech Packaging

    Orthopedic Solutions from Man’s Best Friend

    The FDA’s Flip-Flop on Hyaluronic Acid

    HSS, Zimmer Biomet's Solution for the Episode of Orthopedic Care
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    NN Life Sciences/Paragon Medical

    Carpenter Technology

    Edge International/Supra Alloys

    MedTorque Inc.

    Structure Medical
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Breaking News

    CMS Expedites Breakthrough Device Access; Industry Applauds

    New rule creates an accelerated Medicare coverage pathway for innovative products that the FDA deems ‘breakthrough.’

    CMS Expedites Breakthrough Device Access; Industry Applauds
    This action represents a step forward that will help smooth the Medicare coverage pathway for innovative products, resulting in faster access to new devices for America’s seniors.
    Related CONTENT
    • Global Bone Tumor Ablation Devices Market to Top $111 Million by 2027
    • Incorporate Packaging, Sterilization Early in Product Design to Avoid Costly Mistakes
    • GreenBone Ortho Closes 10 Million Euros Series B Funding Round
    • SynerFuse, Cirtec Medical Partner to Develop Back Pain Management Device
    • New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    ODT Staff01.13.21
    On January 12, the Centers for Medicare & Medicaid Services (CMS) issued a final rule that propels innovative technology so Medicare beneficiaries have access to the latest, most advanced devices.
     
    This action represents a step forward that will help smooth the Medicare coverage pathway for innovative products, resulting in faster access to new devices for America’s seniors.
     
    “Government processes have slowed beneficiaries’ access to innovative treatments. Despite being deemed safe and effective by the FDA, Medicare beneficiaries have not had predictable, immediate access to innovative breakthrough devices,” said CMS Administrator Seema Verma. “In an ever-evolving health care marketplace, CMS remains committed to transforming the health care delivery system through initiatives like MCIT that focus on results, removing government barriers to advancing innovations, fostering competition, and ensuring quicker access to the most advanced therapies for Medicare beneficiaries while providing them with better value and outcomes.”
     
    Eliminating Lag Time for Seniors and Innovators
    The Medicare Coverage of Innovative Technology (MCIT) (CMS-3372-F) final rule will provide the nation’s more than 60 million Medicare beneficiaries access to the latest medical technology faster than ever. Under current rules, FDA approval of a device is followed by an often lengthy and costly process for Medicare coverage. This causes undue burden for innovators and could delay access to these potentially lifesaving technologies during the existing Medicare coverage determination process.
     
    The MCIT rule will eliminate this lag time for both seniors and innovators. It will create a new, accelerated Medicare coverage pathway for innovative products that the FDA deems “breakthrough,” which FDA approves on an expedited basis and could include devices harnessing new technologies like implants or gene-based tests to diagnose or treat life-threatening or irreversibly debilitating diseases or conditions like cancer and heart disease.
     
    Under the MCIT rule, Medicare can provide national coverage simultaneously with FDA approval, up to a period of four years. After the coverage period is over, CMS will reevaluate the device based on clinical and real-world evidence of improvement in health outcomes among Medicare beneficiaries to determine more permanent coverage. This four-year timeline may incentivize the manufacturers of these breakthrough devices to develop additional evidence regarding the applicability of their products to the Medicare population, so they might continue Medicare coverage beyond the initial four years.
     
    Importantly, because the MCIT rule will provide national Medicare coverage for four years, it will harmonize with the local coverage determination (LCD) process, thus promoting equal access for seniors regardless of where they live.
     
    Simplifying the Process
    Additionally, to secure an LCD, innovators are required to seek separate decisions from each of the MACs. MCIT makes this step for innovators unnecessary, which helps innovators and beneficiaries alike. Under MCIT, breakthrough devices are given national coverage for four years, as early as the date of FDA approval, meaning innovators no longer have to seek LCDs from each MAC. Innovators will have the option to choose when they would like coverage to begin. This will give innovators flexibility to align the coverage process with their manufacturing and distribution cycles.
     
    After the final rule takes effect, upon manufacturer request, Medicare may cover through MCIT eligible breakthrough devices the FDA has approved, including breakthrough devices that received FDA marketing authorization approval within two calendar years prior to the final rule’s effective date, giving Medicare beneficiaries access to these innovative and potentially life-saving devices.
     
    In addition, the MCIT final rule will clarify the standard CMS uses to determine whether Medicare should cover items and services, like devices and surgical procedures. Under the Medicare law, with relatively few exceptions, the program can only cover items or services that are “reasonable and necessary” for the diagnosis or treatment of illness or injury or improve the functioning of a malformed body member. This final rule will codify CMS’s definition of reasonable and necessary in regulation to give innovators a clearer understanding of CMS standards. 
     
    Reactions from Industry
    The Medical Device Manufacturers Association’s (MDMA) president and CEO Mark Leahey issued the following statement applauding CMS’ final rule:
     
    “CMS’ final rule to accelerate coverage for breakthrough technologies will allow our nation’s seniors to benefit from innovative solutions to their health care needs. MDMA continues to advocate for updated coverage policies that would allow innovative therapies and technologies to get into the hands of patients and physicians in an expedited manner, and the MCIT final rule is a major step towards achieving this goal. We remain focused on working with all stakeholders to continue improving the reimbursement landscape so that patients throughout the United States get timely access to medical technology innovation.”
     
    AdvaMed president and CEO Scott Whitaker also commended CMS on the rule:
     
    “Today’s announcement by CMS Administrator Verma will help ensure Medicare beneficiaries will benefit from breakthrough technologies. On behalf of our industry and the potentially millions of seniors who stand to benefit from these lifechanging innovations, we applaud the Adminstrator’s leadership and thank her and her team for taking this important step forward.
     
    “Under the new MCIT rule, as soon as the FDA approves a new breakthrough technology, Medicare can cover that breakthrough technology. It’s that simple—and it should be that simple. It means that when a device or diagnostic test that is designated as a breakthrough and determined by the FDA to be safe and effective, Medicare patients can be the first in line to get it when their doctors determine it is necessary.  
     
    “It’s good government, and it’s good common sense to recognize that if doctors and scientists at the FDA—the global gold standard for medical technology regulation—determine a device is safe and effective, another federal agency can then move quickly to ensure patients can access that lifechanging and often lifesaving technology. We urge the incoming administration to keep this important step forward for our seniors in place, and we look forward to working closely with them on its implementation.”
    Suggested For You
    Global Bone Tumor Ablation Devices Market to Top $111 Million by 2027 Global Bone Tumor Ablation Devices Market to Top $111 Million by 2027
    Incorporate Packaging, Sterilization Early in Product Design to Avoid Costly Mistakes Incorporate Packaging, Sterilization Early in Product Design to Avoid Costly Mistakes
    GreenBone Ortho Closes 10 Million Euros Series B Funding Round GreenBone Ortho Closes 10 Million Euros Series B Funding Round
    SynerFuse, Cirtec Medical Partner to Develop Back Pain Management Device SynerFuse, Cirtec Medical Partner to Develop Back Pain Management Device
    New Biosealant Could Stabilize Cartilage, Boost Healing After Injury New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    HSS and LimaCorporate Open Provider-Based 3D Design and Printing Facility HSS and LimaCorporate Open Provider-Based 3D Design and Printing Facility
    Usability, Sustainability Becoming More Relevant in Medtech Packaging Usability, Sustainability Becoming More Relevant in Medtech Packaging
    FDA Approves NuVasive FDA Approves NuVasive's Simplify Disc for Two-Level Cervical Total Disc Replacement
    Empirical Spine Empirical Spine's LimiFlex Device Granted Breakthrough Designation Status
    FDA Clears Orthofix FDA Clears Orthofix's 3D-Printed Titanium Cervical Spacer System
    MedTorque Promotes Chad Ryshkus to VP, Commercial Operations MedTorque Promotes Chad Ryshkus to VP, Commercial Operations
    Augmedics Raises $36 Million in Series C Financing Augmedics Raises $36 Million in Series C Financing
    Encora Encora's Tremor Reducing Wristband Gains Breakthrough Status
    Premia Spine Premia Spine's TOPS Spinal Arthroplasty System Earns Breakthrough Status
    Zimmer Biomet Unveils ZBEdge Suite of Digital and Robotic Technologies Zimmer Biomet Unveils ZBEdge Suite of Digital and Robotic Technologies

    Related Breaking News

    • Biologics
      Biogennix Rolls Out Agilon Strip Bone Graft

      Biogennix Rolls Out Agilon Strip Bone Graft

      Agilon Strip maximizes direct contact with bone when implanted.
      Sam Brusco, Associate Editor 04.14.21

    • Global Bone Tumor Ablation Devices Market to Top $111 Million by 2027

      Global Bone Tumor Ablation Devices Market to Top $111 Million by 2027

      Annual growth to average 10.2 percent, industry estimates forecast.
      Michael Barbella, Managing Editor 04.14.21

    • GreenBone Ortho Closes 10 Million Euros Series B Funding Round

      GreenBone Ortho Closes 10 Million Euros Series B Funding Round

      Investment follows CE Marking of the company's bone regeneration scaffold.
      Michael Barbella, Managing Editor 04.13.21


    • Spine/Neurology
      SynerFuse, Cirtec Medical Partner to Develop Back Pain Management Device

      SynerFuse, Cirtec Medical Partner to Develop Back Pain Management Device

      Collaboration is focused on development of the NeuroFuse DRG therapy.
      Michael Barbella, Managing Editor 04.12.21

    • Materials | Trauma/Sports
      New Biosealant Could Stabilize Cartilage, Boost Healing After Injury

      New Biosealant Could Stabilize Cartilage, Boost Healing After Injury

      Research shows using a hyaluronic acid hydrogel system temporarily stops cartilage degeneration that commonly occurs after injury.
      Sam Brusco, Associate Editor 04.09.21

    • Spine/Neurology
      Google Executive Joins SeaSpine

      Google Executive Joins SeaSpine's Board of Directors

      Shweta Singh Maniar leads the visions, strategy and execution of Google Cloud’s industry product strategy.
      Michael Barbella, Managing Editor 04.09.21


    • HSS and LimaCorporate Open Provider-Based 3D Design and Printing Facility

      HSS and LimaCorporate Open Provider-Based 3D Design and Printing Facility

      Creates faster access to more personalized solutions to highly complex orthopedic conditions.
      Charles Sternberg, Assistant Editor 04.08.21

    • Spine/Neurology
      Study: Spinal Fixation Rods Can Improve Patient Outcomes

      Study: Spinal Fixation Rods Can Improve Patient Outcomes

      Products allow surgeons the freedom to place rods based on patient anatomy.
      Michael Barbella, Managing Editor 04.08.21

    • Orchid Welcomes New CFO

      Orchid Welcomes New CFO

      Matt Tharp joins the company with over 20 years of experience in supply chain, operations, and finance.
      Charles Sternberg, Assistant Editor 04.07.21


    • Spine/Neurology
      FDA Approves NuVasive

      FDA Approves NuVasive's Simplify Disc for Two-Level Cervical Total Disc Replacement

      Implant achieved the highest overall clinical success rate at both one- and two-levels compared to any other approved cervical disc.
      Michael Barbella, Managing Editor 04.07.21

    • Spine/Neurology
      Empirical Spine

      Empirical Spine's LimiFlex Device Granted Breakthrough Designation Status

      Product targets degenerative spondylolisthesis.
      Michael Barbella, Managing Editor 04.06.21

    • Spine/Neurology
      FDA Clears Orthofix

      FDA Clears Orthofix's 3D-Printed Titanium Cervical Spacer System

      Designed with nanoscale surface features, the CONSTRUX Mini Ti System is Orthofix’s first 3D-printed titanium interbody introduced to the market.
      Michael Barbella, Managing Editor 04.05.21


    • MedTorque Promotes Chad Ryshkus to VP, Commercial Operations

      MedTorque Promotes Chad Ryshkus to VP, Commercial Operations

      Executive will now be responsible for driving Voice of the Customer into all corners of the enterprise.
      Michael Barbella, Managing Editor 04.01.21

    • Augmedics Raises $36 Million in Series C Financing

      Augmedics Raises $36 Million in Series C Financing

      Money will be used to continue commercialization of xvision Spine.
      Michael Barbella, Managing Editor 04.01.21

    • Extremities | Spine/Neurology
      Encora

      Encora's Tremor Reducing Wristband Gains Breakthrough Status

      Indicated to provide temporary hand tremor relief in adult essential tremor or Parkinson's patients.
      Sam Brusco, Associate Editor 03.31.21


    Trending
    • Mini MRI For Hand And Wrist Imaging Can Be Used Nearly Anywhere
    • Aurora Spine Receives FDA 510(k) Clearance For Anterior Cervical Plate System
    • Incorporate Packaging, Sterilization Early In Product Design To Avoid Costly Mistakes
    • Four-Year Conformis ITotal CR Data Shows Lower Risk Of Revision
    • Mini MRI for Hand and Wrist Imaging Can Be Used Nearly Anywhere
    Breaking News
    • Biogennix Rolls Out Agilon Strip Bone Graft
    • Global Bone Tumor Ablation Devices Market to Top $111 Million by 2027
    • GreenBone Ortho Closes 10 Million Euros Series B Funding Round
    • SynerFuse, Cirtec Medical Partner to Develop Back Pain Management Device
    • New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    View Breaking News >
    CURRENT ISSUE

    March/April 2021

    • Development Options: Orthopedic Device Design
    • I, Surgical Robot
    • Printer-Friendly: An Additive Manufacturing Update
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    BIO-CAT Microbials’ OPTI-BIOME Probiotic Strain Receives FDA “Letter of No Objection” on GRAS Status
    6th Annual Dietary Supplements Regulatory Summit Scheduled for July 13
    Bunge Invests $47.5 Million in Australian Plant Proteins
    Coatings World

    Latest Breaking News From Coatings World

    Jebsen & Jessen, Innospec Sign Distribution Agreement
    VideoBite: Engineered Polymer Solutions
    Shepherd Color Unveils Bismuth Vanadate Yellow Pigment
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Medtronic Introduces Extended Infusion Set in Europe
    BioSig Launches Software Update for PURE EP Electrophysiology Platform
    Katena Acquires Ophthalmic Surgical Instrument Maker ASICO
    Contract Pharma

    Latest Breaking News From Contract Pharma

    BioVersys Gets EIB Funds to Address Antimicrobial Resistance
    Microbiologics Expands Virology Services
    ATMPS, Ori Biotech Integrate Digital Platform for Cell & Gene Therapies
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Cosmoprof Worldwide Bologna Postpones 2021 Show
    Native Launches Broad Spectrum SPF 30 Mineral Sunscreens
    Revieve Launches Skin Coach
    Happi

    Latest Breaking News From Happi

    Hallstar Beauty Names New President
    The Fragrance Foundation Announces the 2021 Awards Finalists
    Azelis Earns 'Coup de Coeur' Award at Cosmetagora 2021
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Epson SurePress reaches milestone
    Maxcess updates user interface for Fife guiding Sensor
    Bobst announces virtual packaging industry event
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    PCMC Redesigns Rx200 and Mako Clipper Wet Wipes Machines
    PFNonwovens Adding New Capabilities in Znojmo
    Russ Torres Named Group President of Kimberly-Clark North America
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Biogennix Rolls Out Agilon Strip Bone Graft
    Global Bone Tumor Ablation Devices Market to Top $111 Million by 2027
    GreenBone Ortho Closes 10 Million Euros Series B Funding Round
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence
    European Commission's Innovation Radar Acknowledges 3 ARMOR Innovations
    SUPERSMART Wins 'Best Publicly Funded Project Demonstrator' in 2021 OE-A Competition

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login